Skip to content

Participant Login Provider Login Support

Home
>Resources

Discover How Helix is Changing the World of Healthcare

Resources Hub

Get in touch

Weaving Genomics into the Fabric of Healthcare

Contact us:

Customer Support: (844) 211 2070 Monday - Friday: 6 AM – 6 PM (Pacific)

© 2016-2025 Helix, Inc. All rights reserved.

Helix, the Helix logo, Exome+, and Sequence Once, Query Often are trademarks of Helix, Inc.

Resources

Blog
Research
All Resources

Who we serve

Health Systems
Life Sciences
Public Health

Company

About Us
News
Press Releases
Careers

Contact Us

Partnerships
Participant Support

Participant Support

Contact Support
Help Center

Privacy Notice
Terms of Service
Notice of Privacy Practices
Consumer Health Privacy Policy
Accessibility
Your Privacy Choices

CLIA #05D2117342
CAP #9382893

The Latest Content From Helix

Recent Blog Posts

View All Blog Posts

Partnering with Veracyte to Deliver More Complete Genomic Insights in Prostate Cancer Care

From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.

By James Lu, MD, PhD, CEO and Co-Founder of Helix

Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Recent Press Releases

View All Press Releases

Parkview expands DNA Insights program to the public

September 9, 2025

Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Recent Videos

View All Videos

Partner Perspectives with Nebraska Medicine

Genetic Insights Project helps Nebraskans take charge of their health

Partner Perspectives with MUSC - Update

Revolutionizing Healthcare: In Our DNA SC

Partner Perspectives with Renown Health - Update

The Healthy Nevada Project - update 2023

Recent Published Research

View All Published Research

1

Published Research

From Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World Evidence

August 15, 2025

2

Published Research

Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort

3

Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

4

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

5

Published Research

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Recent Whitepapers

View All Whitepapers

Performance and Applications of Helix Exome+^® Assay

October 7, 2024

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

January 3, 2024

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

October 11, 2023

The Latest Content From Helix

Recent Blog Posts

View All Blog Posts

Partnering with Veracyte to Deliver More Complete Genomic Insights in Prostate Cancer Care

From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.

By James Lu, MD, PhD, CEO and Co-Founder of Helix

Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Recent Press Releases

View All Press Releases

Parkview expands DNA Insights program to the public

September 9, 2025

Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Recent Videos

View All Videos

Partner Perspectives with Nebraska Medicine

Genetic Insights Project helps Nebraskans take charge of their health

Partner Perspectives with MUSC - Update

Revolutionizing Healthcare: In Our DNA SC

Partner Perspectives with Renown Health - Update

The Healthy Nevada Project - update 2023

Recent Published Research

View All Published Research

1

Published Research

From Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World Evidence

August 15, 2025

2

Published Research

Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort

3

Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

4

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

5

Published Research

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Recent Whitepapers

View All Whitepapers

Performance and Applications of Helix Exome+^® Assay

October 7, 2024

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

January 3, 2024

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

October 11, 2023

Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance

Press Releases

Jun 3, 2021

Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance

Genetic Screening for the Whole Population

Podcasts

May 28, 2021

Genetic Screening for the Whole Population

The Incrementalist: Genetic Screening for the Whole Population with James Lu MD PhD

Podcasts

May 28, 2021

The Incrementalist: Genetic Screening for the Whole Population with James Lu MD PhD

HealthcareNOW

Marc Stapley Assumes Role of Executive Chairman of the Board of Directors of Helix; President and Co-founder James Lu Appointed President and Chief Executive Officer

Press Releases

May 6, 2021

Marc Stapley Assumes Role of Executive Chairman of the Board of Directors of Helix; President and Co-founder James Lu Appointed President and Chief Executive Officer

Evidence of “double mutant” substitutions E484Q and L452R in the B.1.429 lineage suggest convergent evolution of immune escape mutations

Blog

May 4, 2021

Evidence of “double mutant” substitutions E484Q and L452R in the B.1.429 lineage suggest convergent evolution of immune escape mutations

Comprehensive allele genotyping in critical pharmacogenes reduces residual clinical risk in diverse populations

Research

Apr 30, 2021

Comprehensive allele genotyping in critical pharmacogenes reduces residual clinical risk in diverse populations

CLINICAL PHARMACOLOGY & THERAPEUTICS

Ginkgo and Helix Partner on Pooled COVID Testing for Schools

News

Apr 20, 2021

Ginkgo and Helix Partner on Pooled COVID Testing for Schools

Government Technology

Helix Announces Partnership with Ginkgo Bioworks to Support Back to School COVID-19 Testing Across the Western U.S.

Press Releases

Apr 8, 2021

Helix Announces Partnership with Ginkgo Bioworks to Support Back to School COVID-19 Testing Across the Western U.S.

As Variants Have Spread, Progress Against the Virus in U.S. Has Stalled

News

Apr 6, 2021

As Variants Have Spread, Progress Against the Virus in U.S. Has Stalled

The New York Times

Page 31